Remote prescribing for toxin — keep getting confused by the rules
Can someone sanity-check the current position on remote prescribing for botulinum toxin in the UK? Want to make sure I'm compliant.
For licensed aesthetic professionals only. Guidance here supports — and never replaces — your clinical judgement. Do not upload identifiable patient data.
Can someone sanity-check the current position on remote prescribing for botulinum toxin in the UK? Want to make sure I'm compliant.
In the UK, prescription-only medicines like botulinum toxin require an in-person consultation by the prescriber before prescribing — remote-only prescribing isn't appropriate. Follow your regulator's current guidance (GMC/GPhC/NMC) and work closely with your prescriber. Always check for the latest position as guidance evolves.
The short version for the UK: GMC guidance is that you must not prescribe injectable cosmetic medicines like botulinum toxin remotely — the prescriber has to carry out a physical, face-to-face assessment of the patient before prescribing. A phone or video 'sign-off' without seeing the patient in person is not acceptable for these medicines. So your prescriber needs to actually assess the patient, not just approve a list of names.
Exactly this. If your business model relies on a prescriber who never meets the patient, it needs rethinking. The safest and most defensible setup is prescriber-led, face-to-face assessment with clear records of who prescribed, when and on what basis.
Sign in to reply and react.